Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
about
CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat proteinRole of Bruton's tyrosine kinase inhibitors in HIV-1-infected cellsImproving combination antiretroviral therapy by targeting HIV-1 gene transcription.Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK.
P2860
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@en
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@nl
type
label
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@en
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@nl
prefLabel
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@en
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@nl
P2093
P2860
P356
P1433
P1476
Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
@en
P2093
Aarthi Narayanan
Benjamin Lepene
Elizabeth Jaworski
Fatah Kashanchi
Gavin C Sampey
Irene Guendel
Kylene Kehn-Hall
Leonard Shultz
P2860
P304
P356
10.1128/JVI.01940-13
P407
P50
P577
2013-11-13T00:00:00Z